3/29/2019CMSC INforMS: Novartis gets FDA approval for Mayzent (siponimod), the first oral drug to treat SPMS
3/27/2019CMSC INforMS: Novartis receives FDA approval for MAYZENT (siponimod)
3/26/2019CMSC INforMS: Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis
3/14/2019CMSC INforMS: BrainStorm Announces First Patient in Phase 2 Clinical Trial Progressive MS
2/19/2019CMSC INforMS: Depression, Psychological Distress Symptoms Affect MS Patients’ Quality of Life
5/28/2019 » 6/1/2019
2019 CMSC Annual Meeting (Seattle, WA)
5/31/2019
More About MS
5/20/2020 » 5/23/2020
2020 CMSC Annual Meeting (Orlando, FL)
6/2/2021 » 6/5/2021
2021 CMSC Annual Meeting (San Diego, CA)
Print Page